Application of Al18F-NOTA-FAPI PET/CT in Malignant Tumors Expressing Fibroblast-activated Proteins

PHASE2/PHASE3RecruitingINTERVENTIONAL

Enrollment

500

Participants

Timeline

Start Date

January 8, 2023

Primary Completion Date

March 8, 2025

Study Completion Date

January 8, 2026

Conditions

Malignancy

Interventions

DRUG

Al18F-NOTA-FAPI

Al18F-NOTA-FAPI was injected into the patients before the PET/CT scans

Trial Locations (1)

RECRUITING

National Cancer Center/Cancer Hospital,Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing

All Listed Sponsors

lead

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

OTHER